Abstract
Pseudomonas aeruginosa infection continues to be a threat to cancer patients, especially if they are neutropenic. As many as 50% of infections are community acquired. Prompt, effective therapy results in cures in about 80% of patients, although the presence of shock or pneumonia indicates a poor prognosis. Antibiotic resistance is an increasing problem.